This month, the Secretary of the U.S. Department of Health and Human Services (HHS) – Robert F. Kennedy, Jr. – testified at seven congressional committee hearings, offering some good insight into where the Trump Administration intends to go on healthcare policy in the months ahead.
HHS appears to be clarifying its priorities, with an agenda centered on price transparency, program integrity, and structural reform across both public and private health insurance markets.
A central theme emerging from Kennedy’s appearances before House and Senate committees is skepticism toward the current structure of Patient Protection and Affordable Care Act (PPACA) marketplaces. In testimony before House lawmakers, he sharply criticized the methods that have contributed to lower premiums in recent years, arguing that tax subsidies and relaxed enrollment policies have created only the “illusion” of affordability, rather than addressing underlying healthcare costs. This framing suggests the Administration may be preparing to revisit how PPACA coverage is subsidized and regulated, potentially favoring policies that emphasize cost containment over expanded financial assistance.
Closely tied to this approach is the Administration’s renewed push for healthcare price transparency. Kennedy highlighted the need for stronger statutory provisions that would require Medicare and Medicaid plans to publicly disclose pricing in a more accessible and standardized way. By urging Congress to advance the president’s “Great Healthcare Plan,” HHS says it is placing transparency at the center of its agenda. The underlying idea is that clearer pricing information will increase competition and ultimately drive down costs, though the effectiveness of such measures remains a subject of debate among policymakers and industry stakeholders.
Another notable HHS priority is reform of preventive care regulation. Kennedy’s criticism of the U.S. Preventive Services Task Force – that’s the body that determines which preventive services insurers must cover – indicates ongoing dissatisfaction with the current pace and direction of the Task Force’s decision-making.
As a result, the Secretary initiated a call for nominations to replace the 16-member panel, and is clearly prepared to reshape how preventive care recommendations are developed. This move could have far-reaching implications, as the panel’s determinations directly influence insurance coverage requirements and patient access to preventive services.
Beyond regulatory and policy reforms, the Administration is also prioritizing program integrity, particularly within Medicaid. Under Kennedy’s direction, Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz announced last week a nationwide initiative to combat Medicaid fraud, requiring states to rapidly revalidate providers and submit detailed anti-fraud strategies. This effort is being reinforced by coordination with the U.S. Department of Justice (DOJ), which is intensifying enforcement actions in areas such as PPACA marketplace fraud.
Together, these measures reveal a broader emphasis on safeguarding federal healthcare spending and reducing fraud, waste, and abuse.
The convergence of these initiatives – PPACA marketplace scrutiny, transparency mandates, preventive care restructuring, and anti-fraud enforcement – exposes a fairly coherent policy direction. Rather than focusing primarily on expanding coverage, the Administration appears intent on tightening oversight, increasing accountability, and addressing system inefficiencies.
However, these priorities also raise some important questions. We’ve already seen that efforts to reduce PPACA subsidies and alter enrollment practices affect coverage levels.
Changes to the Preventive Services Task Force may introduce new debates over the role of evidence-based medicine versus political influence in determining preventive care standards. And while transparency and anti-fraud measures are broadly supported, their real-world impact still depends on implementation and enforcement.
Ultimately, Kennedy’s recent tour testifying before congressional committees offers a window into how the Administration wants to move forward on federal healthcare policy. So stay tuned, because we’ve learned where HHS’s focus lies – on transparency, integrity, affordability, and structural reform – which may result in some significant policy activity that influences how Americans access, pay for, and understand their healthcare.
Healthcare policy has always involved a degree of uncertainty. I have been in healthcare for over 40 years, and early in my career we would
The Centers for Medicare & Medicaid Services (CMS) continues to expand its focus on hospital readmissions in the FY 2027 IPPS (Inpatient Prospective Payment System)
Please log in to your account to comment on this article.
Breast biopsy procedures may be clinically straightforward but accurately translating them into compliant billing can be anything but. In this focused webcast, Shawn Blackburn, CPC, CPMA, CIC, CRC, CCS-P breaks down how imaging guidance, lesion count, laterality, and payer expectations all impact how these procedures should be reported. Through clear explanations and real-world scenarios, you’ll gain practical insight into aligning clinical workflows with billing requirements, avoiding common pitfalls, and ensuring your documentation supports accurate reimbursement and compliance.
Gain clarity and confidence in OB‑GYN coding with this expert‑led webcast featuring Sherri L. Clayton, RHIT, CSS. You’ll learn how to apply global maternity package rules accurately, select the right CPT codes for procedures and visits, and identify documentation gaps that lead to denials. With practical guidance and real examples, this session helps you strengthen compliance, reduce audit risk, and ensure accurate reimbursement for women’s health services.
Uncover essential coding insights with nationally recognized coding authority Kay Piper, RHIA, CDIP, CCS. Through ICD10monitor’s interactive, on‑demand webcast series, Kay walks you through the AHA’s 2026 ICD‑10‑CM/PCS Quarterly Coding Clinics, translating each update into practical, easy‑to‑apply guidance designed to sharpen precision, ensure compliance, and strengthen day‑to‑day decision‑making. Available shortly after each official release.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s fourth quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Traditional utilization management models can no longer keep pace with regulatory shifts, payer scrutiny, and operational pressures. In this webcast, Tiffany Ferguson, LMSW, CMAC, ACM, ACPA-C, introduces an Adaptive Model strategy that modernizes UM through role specialization, technology-driven workflows, and proactive, team-based processes. Attendees will learn how to restructure programs to improve efficiency, strengthen clinical collaboration, and enhance financial performance in a rapidly changing healthcare environment.
Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →
Have a Medicare regulation question you’d love Dr. Hirsch to answer? Now is your chance! CLICK HERE to learn more→
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
